{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:07:04Z","timestamp":1791612424423,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Hypoparathyroidism is defined by hypocalcemia with inappropriately normal or low parathyroid hormone levels. The current standard treatment consists of lifelong calcium and\/ or vitamin D supplementation. Even while on stable treatment regimens, hypoparathyroid patients might still suffer from symptoms that can negatively impact their quality of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic literature review to identify the current knowledge regarding quality of life in patients with hypoparathyroidism receiving standard treatment was performed on November 1st, 2023. PubMed as well as Web of Science were searched. The systematic review is registered in PROSPERO (#CRD42023470924).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After removal of duplicates, 398 studies remained for title and abstract screening, after which 30 were included for full-text screening. After exclusion of seven studies with five studies lacking a control population, one using a non-validated questionnaire, and one being a subsample of the larger included study, 23 studies were included in this systematic review. The majority of the included studies used a guideline-conform definition of hypoparathyroidism, and the SF-36 was the most often applied tool. Almost all studies (87%) reported statistically significantly lower scores in at least one quality of life domain compared to a norm population or controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with hypoparathyroidism receiving standard treatment report impairments in quality of life. The reasons for these impairments are probably multifaceted, making regular monitoring and the inclusion of various professionals necessary.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-024-03807-2","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T06:01:58Z","timestamp":1712296918000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-8257","authenticated-orcid":false,"given":"Matthias","family":"B\u00fcttner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7964","authenticated-orcid":false,"given":"Susanne","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-5789","authenticated-orcid":false,"given":"Katherine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"3807_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"M. Mannstadt, J.P. Bilezikian, R.V. Thakker, F.M. Hannan, B.L. Clarke, L. Rejnmark, D.M. Mitchell, T.J. Vokes, K.K. Winer, D.M. Shoback, Hypoparathyroidism. Nat. Rev. Dis. Prim. 3, 17055 (2017)","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"3807_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"Shoback D Clinical practice","year":"2008","unstructured":"Shoback D Clinical practice, Hypoparathyroidism. N. Engl. J. Med 359(4), 391\u2013403 (2008)","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"3807_CR3","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle, A.A. Khan, M. Peacock, M. Raffaelli, B.C. Silva, R.V. Thakker, T. Vokes, R. Bouillon, Presentation of Hypoparathyroidism: Etiologies and Clinical Features. J. Clin. Endocrinol. Metab. 101(6), 2300\u20132312 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"3807_CR4","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.21037\/gs.2017.09.03","volume":"6","author":"O Edafe","year":"2017","unstructured":"O. Edafe, S.P. Balasubramanian, Incidence, prevalence and risk factors for post-surgical hypocalcaemia and hypoparathyroidism. Gland Surg. 6(Suppl 1), S59\u2013S68 (2017)","journal-title":"Gland Surg."},{"issue":"8","key":"3807_CR5","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"M.C. Astor, K. Lovas, A. Debowska, E.F. Eriksen, J.A. Evang, C. Fossum, K.J. Fougner, S.E. Holte, K. Lima, R.B. Moe, A.G. Myhre, E.H. Kemp, B.G. Nedrebo, J. Svartberg, E.S. Husebye, Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 101(8), 3045\u20133053 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3807_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/0026-0495(81)90136-0","volume":"30","author":"CG Watson","year":"1981","unstructured":"C.G. Watson, D.L. Steed, A.G. Robinson, L.J. Deftos, The role of calcitonin and parathyroid hormone in the pathogenesis of post-thyroidectomy hypocalcemia. Metabolism 30(6), 588\u2013589 (1981)","journal-title":"Metabolism"},{"issue":"2","key":"3807_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00223-018-0405-5","volume":"103","author":"L Cianferotti","year":"2018","unstructured":"L. Cianferotti, S. Parri, G. Gronchi, G. Marcucci, C. Cipriani, J. Pepe, M. Raglianti, S. Minisola, M.L. Brandi, Prevalence of chronic hypoparathyroidism in a Mediterranean region as estimated by the analysis of anonymous healthcare database. Calcif. Tissue Int 103(2), 144\u2013150 (2018)","journal-title":"Calcif. Tissue Int"},{"issue":"3","key":"3807_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00223-016-0222-7","volume":"100","author":"C Cipriani","year":"2017","unstructured":"C. Cipriani, J. Pepe, F. Biamonte, R. Manai, P. Biondi, L. Nieddu, L. Cianferotti, M.L. Brandi, S. Minisola, The epidemiology of hypoparathyroidism in Italy: an 8-year register-based study. Calcif. Tissue Int. 100(3), 278\u2013285 (2017)","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"3807_CR9","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"B.L. Clarke, E.M. Brown, M.T. Collins, H. Juppner, P. Lakatos, M.A. Levine, M.M. Mannstadt, J.P. Bilezikian, A.F. Romanischen, R.V. Thakker, Epidemiology and Diagnosis of Hypoparathyroidism. J. Clin. Endocrinol. Metab. 101(6), 2284\u20132299 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"3807_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Min. Res. 28(11), 2277\u20132285 (2013)","journal-title":"J. Bone Min. Res."},{"issue":"9","key":"3807_CR11","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, The epidemiology of nonsurgical hypoparathyroidism in Denmark: a Nationwide case finding study. J. Bone Min. Res. 30(9), 1738\u20131744 (2015)","journal-title":"J. Bone Min. Res."},{"issue":"3","key":"3807_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jbmr.3329","volume":"33","author":"T Vadiveloo","year":"2018","unstructured":"T. Vadiveloo, P.T. Donnan, G.P. Leese, A population-based study of the epidemiology of chronic hypoparathyroidism. J. Bone Min. Res. 33(3), 478\u2013485 (2018)","journal-title":"J. Bone Min. Res."},{"issue":"2","key":"3807_CR13","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"J. Bollerslev, L. Rejnmark, C. Marcocci, D.M. Shoback, A. Sitges-Serra, W. van Biesen, O.M. Dekkers, European society of E European Society of Endocrinology Clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 173(2), G1\u2013G20 (2015)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3807_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12020-023-03443-2","volume":"82","author":"M Buttner","year":"2023","unstructured":"M. Buttner, D. Krogh, H. Siggelkow, S. Singer, Impairments in quality of life and predictors of symptom burden in patients with hypoparathyroidism: results from a population-based survey. Endocrine 82(2), 419\u2013426 (2023)","journal-title":"Endocrine"},{"issue":"7","key":"3807_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4158\/EP13328.OR","volume":"20","author":"N Hadker","year":"2014","unstructured":"N. Hadker, J. Egan, J. Sanders, H. Lagast, B.L. Clarke, Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr. Pract. 20(7), 671\u2013679 (2014)","journal-title":"Endocr. Pract."},{"issue":"7","key":"3807_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/thy.2017.0309","volume":"28","author":"LA Orloff","year":"2018","unstructured":"L.A. Orloff, S.M. Wiseman, V.J. Bernet, T.J. Fahey 3rd, A.R. Shaha, M.L. Shindo, S.K. Snyder, B.C. Stack Jr, J.B. Sunwoo, M.B. Wang, American Thyroid Association Statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28(7), 830\u2013841 (2018)","journal-title":"Thyroid"},{"issue":"1","key":"3807_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"A.A. Khan, M.R. Rubin, P. Schwarz, T. Vokes, D.M. Shoback, C. Gagnon, A. Palermo, C. Marcocci, B.L. Clarke, L.G. Abbott, L.C. Hofbauer, L. Kohlmeier, S. Pihl, X. An, W.F. Eng, A.R. Smith, J. Ukena, C.T. Sibley, A.D. Shu, L. Rejnmark, Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial. J. Bone Min. Res. 38(1), 14\u201325 (2023)","journal-title":"J. Bone Min. Res."},{"issue":"9","key":"3807_CR18","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1210\/jc.2015-1855","volume":"100","author":"A Santonati","year":"2015","unstructured":"A. Santonati, A. Palermo, E. Maddaloni, D. Bosco, A. Spada, F. Grimaldi, B. Raggiunti, R. Volpe, S. Manfrini, F. Vescini, A.M.E.G. Hypoparathyroidism, PTH(1-34) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metab. 100(9), 3590\u20133597 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"3807_CR19","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1210\/jc.2018-02430","volume":"104","author":"G Tabacco","year":"2019","unstructured":"G. Tabacco, Y.D. Tay, N.E. Cusano, J. Williams, B. Omeragic, R. Majeed, M.G. Almonte, M.R. Rubin, J.P. Bilezikian, Quality of life in hypoparathyroidism improves with rhPTH(1-84) throughout 8 years of therapy. J. Clin. Endocrinol. Metab. 104(7), 2748\u20132756 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3807_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","volume":"103","author":"TJ Vokes","year":"2018","unstructured":"T.J. Vokes, M. Mannstadt, M.A. Levine, B.L. Clarke, P. Lakatos, K. Chen, R. Piccolo, A. Krasner, D.M. Shoback, J.P. Bilezikian, Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J. Clin. Endocrinol. Metab. 103(2), 722\u2013731 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"3807_CR21","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"K.K. Winer, C.W. Ko, J.C. Reynolds, K. Dowdy, M. Keil, D. Peterson, L.H. Gerber, C. McGarvey, G.B. Cutler Jr, Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J. Clin. Endocrinol. Metab. 88(9), 4214\u20134220 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3807_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12020-017-1377-3","volume":"58","author":"M Buttner","year":"2017","unstructured":"M. Buttner, T.J. Musholt, S. Singer, Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58(1), 14\u201320 (2017)","journal-title":"Endocrine"},{"key":"3807_CR23","volume":"46","author":"MJ Page","year":"2022","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hrobjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: una guia actualizada para la publicacion de revisiones sistematicas]. Rev. Panam. Salud Publica 46, e112 (2022)","journal-title":"Rev. Panam. Salud Publica"},{"key":"3807_CR24","unstructured":"Covidence. Available from: https:\/\/www.covidence.org\/."},{"key":"3807_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-154","volume":"13","author":"R Herzog","year":"2013","unstructured":"R. Herzog, M.J. Alvarez-Pasquin, C. Diaz, J.L. Del Barrio, J.M. Estrada, A. Gil, Are healthcare workers\u2019 intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13, 154 (2013)","journal-title":"BMC Public Health"},{"issue":"10","key":"3807_CR26","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1210\/jc.2014-2267","volume":"99","author":"NE Cusano","year":"2014","unstructured":"N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy, J.P. Bilezikian, PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metab. 99(10), 3694\u20133699 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3807_CR27","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","volume":"107","author":"AA Khan","year":"2022","unstructured":"A.A. Khan, L. Rejnmark, M. Rubin, P. Schwarz, T. Vokes, B. Clarke, I. Ahmed, L. Hofbauer, C. Marcocci, U. Pagotto, A. Palermo, E. Eriksen, M. Brod, D. Markova, A. Smith, S. Pihl, S. Mourya, D.B. Karpf, A.D. Shu, PaTH forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism. J. Clin. Endocrinol. Metab. 107(1), e372\u2013e385 (2022)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3807_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jbmr.4452","volume":"37","author":"KL Roszko","year":"2022","unstructured":"K.L. Roszko, T.Y. Hu, L.C. Guthrie, B.A. Brillante, M. Smith, M.T. Collins, R.I. Gafni, PTH 1-34 replacement therapy has minimal effect on quality of life in patients with hypoparathyroidism. J. Bone Min. Res. 37(1), 68\u201377 (2022)","journal-title":"J. Bone Min. Res."},{"issue":"6","key":"3807_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","volume":"25","author":"T Sikjaer","year":"2014","unstructured":"T. Sikjaer, L. Rolighed, A. Hess, A. Fuglsang-Frederiksen, L. Mosekilde, L. Rejnmark, Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos. Int 25(6), 1717\u20131726 (2014)","journal-title":"Osteoporos. Int"},{"issue":"6","key":"3807_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.13593","volume":"88","author":"L Underbjerg","year":"2018","unstructured":"L. Underbjerg, T. Sikjaer, L. Rejnmark, Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism. Clin. Endocrinol. (Oxf.) 88(6), 838\u2013847 (2018)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"7","key":"3807_CR31","volume":"4","author":"D Wilde","year":"2020","unstructured":"D. Wilde, L. Wilken, B. Stamm, C. Heppner, A. Leha, M. Blaschke, C. Herrmann-Lingen, H. Siggelkow, Quantification of symptom load by a disease-specific questionnaire HPQ 28 and analysis of associated biochemical parameters in patients with postsurgical hypoparathyroidism. JBMR 4(7), e10368 (2020)","journal-title":"JBMR"},{"issue":"2","key":"3807_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/eje.0.1460215","volume":"146","author":"W Arlt","year":"2002","unstructured":"W. Arlt, C. Fremerey, F. Callies, M. Reincke, P. Schneider, W. Timmermann, B. Allolio, Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur. J. Endocrinol. 146(2), 215\u2013222 (2002)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"3807_CR33","first-page":"319","volume":"62","author":"AJ Arneiro","year":"2018","unstructured":"A.J. Arneiro, B.C.C. Duarte, R.M. Kulchetscki, V.B.S. Cury, M.P. Lopes, B.S. Kliemann, I.B. Bini, M. Assad, G.L.K. Biagini, V.Z.C. Borba, C.A. Moreira, Self-report of psychological symptoms in hypoparathyroidism patients on conventional therapy. Arch. Endocrinol. Metab. 62(3), 319\u2013324 (2018)","journal-title":"Arch. Endocrinol. Metab."},{"issue":"12","key":"3807_CR34","doi-asserted-by":"publisher","first-page":"dgaa597","DOI":"10.1210\/clinem\/dgaa597","volume":"105","author":"M Buttner","year":"2020","unstructured":"M. Buttner, L.D. Locati, M. Pinto, C. Araujo, I.M. Tomaszewska, N. Kiyota, E. Vidhubala, C. Brannan, E. Hammerlid, O. Husson, D. Salem, G. Ioannidis, E. Gamper, J.I. Arraras, G. Andry, J. Inhestern, J. Theurer, K. Taylor, S. Singer, Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer. J. Clin. Endocrinol. Metab. 105(12), dgaa597 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3807_CR35","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s40200-023-01292-4","volume":"22","author":"F Cherchir","year":"2023","unstructured":"F. Cherchir, I. Oueslati, M. Yazidi, F. Chaker, M. Chihaoui, Assessment of quality of life in patients with permanent hypoparathyroidism receiving conventional treatment. J. Diabetes Metab. Disord. 22(2), 1617\u20131623 (2023)","journal-title":"J. Diabetes Metab. Disord."},{"issue":"5","key":"3807_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0000000000005129","volume":"274","author":"S Frey","year":"2021","unstructured":"S. Frey, L. Figueres, F. Pattou, M. Le Bras, C. Caillard, M. Mathonnet, A. Hamy, L. Brunaud, J.C. Lifante, C. Tresallet, F. Sebag, F. Menegaux, C. Blanchard, M. Leroy, E. Mirallie, Qol-Hypopara Study G impact of permanent post-thyroidectomy hypoparathyroidism on self-evaluation of quality of life and voice: results from the National QoL-Hypopara study. Ann. Surg. 274(5), 851\u2013858 (2021)","journal-title":"Ann. Surg."},{"issue":"1","key":"3807_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00759-8","volume":"15","author":"S Hepsen","year":"2020","unstructured":"S. Hepsen, P. Akhanli, D. Sakiz, M.E. Sencar, B. Ucan, I.O. Unsal, E. Cakal, M. Ozbek, The effects of patient and disease-related factors on the quality of life in patients with hypoparathyroidism. Arch. Osteoporos. 15(1), 75 (2020)","journal-title":"Arch. Osteoporos."},{"issue":"12","key":"3807_CR38","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00268-022-06730-7","volume":"46","author":"SL Hillary","year":"2022","unstructured":"S.L. Hillary, J.E. Chooi, J. Wadsley, J.D. Newell-Price, N.J. Brown, S.P. Balasubramanian, Quality of life in post-surgical hypoparathyroidism (PoSH) in thyroid and parathyroid surgery. World J. Surg. 46(12), 3025\u20133033 (2022)","journal-title":"World J. Surg."},{"issue":"4","key":"3807_CR39","volume":"5","author":"CU Jorgensen","year":"2021","unstructured":"C.U. Jorgensen, P. Homoe, M. Dahl, M.F. Hitz, Postoperative chronic hypoparathyroidism and quality of life after total thyroidectomy. JBMR 5(4), e10479 (2021)","journal-title":"JBMR"},{"issue":"1","key":"3807_CR40","doi-asserted-by":"publisher","first-page":"e210379","DOI":"10.1530\/EC-21-0379","volume":"11","author":"G Kontogeorgos","year":"2022","unstructured":"G. Kontogeorgos, Z. Mamasoula, E. Krantz, P. Trimpou, K. Landin-Wilhelmsen, C.M. Laine, Low health-related quality of life in hypoparathyroidism and need for PTH analog. Endocr. Connect. 11(1), e210379 (2022)","journal-title":"Endocr. Connect."},{"issue":"3","key":"3807_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40618-021-01686-2","volume":"45","author":"L Mazoni","year":"2022","unstructured":"L. Mazoni, A. Matrone, M. Apicella, F. Saponaro, S. Borsari, E. Pardi, B. Cosci, I. Biagioni, P. Rossi, F. Pacciardi, A. Scionti, R. Elisei, C. Marcocci, F. Cetani, Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study. J. Endocrinol. Invest 45(3), 573\u2013582 (2022)","journal-title":"J. Endocrinol. Invest"},{"issue":"7","key":"3807_CR42","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/jbmr.2812","volume":"31","author":"T Sikjaer","year":"2016","unstructured":"T. Sikjaer, E. Moser, L. Rolighed, L. Underbjerg, L.S. Bislev, L. Mosekilde, L. Rejnmark, Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J. Bone Min. Res. 31(7), 1440\u20131448 (2016)","journal-title":"J. Bone Min. Res."},{"issue":"12","key":"3807_CR43","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s40618-023-02100-9","volume":"46","author":"A Song","year":"2023","unstructured":"A. Song, S. Chen, Y. Yang, Y. Jiang, Y. Jiang, M. Li, W. Xia, O. Wang, X. Xing, PTH level might be associated with impaired quality of life in patients with nonsurgical hypoparathyroidism. J. Endocrinol. Invest 46(12), 2471\u20132479 (2023)","journal-title":"J. Endocrinol. Invest"},{"issue":"6","key":"3807_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"J.E. Ware Jr, C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6), 473\u2013483 (1992)","journal-title":"Med Care"},{"issue":"3","key":"3807_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"C.W. Topp, S.D. Ostergaard, S. Sondergaard, P. Bech, The WHO-5 Well-Being Index: a systematic review of the literature. Psychother. Psychosom. 84(3), 167\u2013176 (2015)","journal-title":"Psychother. Psychosom."},{"issue":"1","key":"3807_CR46","first-page":"13","volume":"9","author":"LR Derogatis","year":"1973","unstructured":"L.R. Derogatis, R.S. Lipman, L. Covi, SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol. Bull. 9(1), 13\u201328 (1973)","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"3807_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF02552842","volume":"217","author":"D von Zerssen","year":"1973","unstructured":"D. von Zerssen, [Self-rating scales for evaluation of patient\u2019s subjective state in cross-sectional and longitudinal studies of psychopathology (author\u2019s transl)]. Arch. Psychiatr. Nervenkr (1970). 217(3), 299\u2013314 (1973)","journal-title":"Arch. Psychiatr. Nervenkr (1970)."},{"issue":"1","key":"3807_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2000-13233","volume":"50","author":"E Brahler","year":"2000","unstructured":"E. Brahler, J. Schumacher, C. Brahler, [First all-Germany standardization of the brief form of the Gissen Complaints Questionnaire GBB-24]. Psychother Psychosom. Med. Psychol. 50(1), 14\u201321 (2000).","journal-title":"Psychother Psychosom. Med. Psychol."},{"issue":"5","key":"3807_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"N.K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N.J. Duez, A. Filiberti, H. Flechtner, S.B. Fleishman, J.C. de Haes et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85(5), 365\u2013376 (1993)","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"3807_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s41687-021-00320-2","volume":"5","author":"M Brod","year":"2021","unstructured":"M. Brod, L. McLeod, D. Markova, J. Gianettoni, S. Mourya, Z. Lin, A. Shu, A. Smith, Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES). J. Patient Rep. Outcomes 5(1), 70 (2021)","journal-title":"J. Patient Rep. Outcomes"},{"issue":"9","key":"3807_CR51","first-page":"1078","volume":"33","author":"S Singer","year":"2023","unstructured":"S. Singer, A. Al-Ibraheem, M. Pinto, I. Iakovou, A.A. Osthus, E. Hammerlid, L.D. Locati, E. Gamper, J. Ignacio, S.J. Jordan, N. Kiyota, M. Buettner, D. Engesser, R. Canotilho, G. Ioannidis, O. Husson, R.R. Gama, G. Fanetti, L. Moss, J. Inhestern, G. Andry, D. Fuehrer, D. Kulis, H. Rimmele, G. Sykiotis, International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34. Thyroid 33(9), 1078\u20131089 (2023)","journal-title":"Thyroid"},{"issue":"1","key":"3807_CR52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12020-019-01858-4","volume":"64","author":"T Harslof","year":"2019","unstructured":"T. Harslof, L. Rolighed, L. Rejnmark, Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review. Endocrine 64(1), 176\u2013183 (2019)","journal-title":"Endocrine"},{"issue":"3","key":"3807_CR53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/hed.21175","volume":"32","author":"HM Mehanna","year":"2010","unstructured":"H.M. Mehanna, A. Jain, H. Randeva, J. Watkinson, A. Shaha, Postoperative hypocalcemia-the difference a definition makes. Head. Neck. 32(3), 279\u2013283 (2010)","journal-title":"Head. Neck."},{"issue":"11","key":"3807_CR54","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s11136-016-1313-7","volume":"25","author":"G Erez","year":"2016","unstructured":"G. Erez, L. Selman, F.E. Murtagh, Measuring health-related quality of life in patients with conservatively managed stage 5 chronic kidney disease: limitations of the Medical Outcomes Study Short Form 36: SF-36. Qual. Life Res. 25(11), 2799\u20132809 (2016)","journal-title":"Qual. Life Res."},{"issue":"3","key":"3807_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/A:1026454503917","volume":"6","author":"JP Hobson","year":"1997","unstructured":"J.P. Hobson, R.J. Meara, Is the SF-36 health survey questionnaire suitable as a self-report measure of the health status of older adults with Parkinson\u2019s disease? Qual. Life Res. 6(3), 213\u2013216 (1997)","journal-title":"Qual. Life Res."},{"issue":"3","key":"3807_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/cen.14701","volume":"97","author":"M Buttner","year":"2022","unstructured":"M. Buttner, D. Krogh, H. Siggelkow, S. Singer, What are predictors of impaired quality of life in patients with hypoparathyroidism? Clin. Endocrinol. (Oxf.) 97(3), 268\u2013275 (2022)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3807_CR57","unstructured":"J.E. KM Ware, J. Bjoermer, D.M. Turner-Bowker, B. Gandek, M. Maruish, SF-36v2 Health survey standard form disease-specific norms, 2nd edn. (Quality Metric Inc, 2007)"},{"issue":"5","key":"3807_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","volume":"56","author":"K Lovas","year":"2002","unstructured":"K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison\u2019s disease. Clin. Endocrinol. (Oxf.) 56(5), 581\u2013588 (2002)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"3807_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-10-0284","volume":"163","author":"I Nermoen","year":"2010","unstructured":"I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453\u2013459 (2010)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3807_CR60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuroscience.2009.04.054","volume":"162","author":"AG Bago","year":"2009","unstructured":"A.G. Bago, E. Dimitrov, R. Saunders, L. Seress, M. Palkovits, T.B. Usdin, A. Dobolyi, Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162(1), 128\u2013147 (2009)","journal-title":"Neuroscience"},{"issue":"2","key":"3807_CR61","first-page":"227","volume":"106","author":"S Balabanov","year":"1984","unstructured":"S. Balabanov, U. Tollner, H.P. Richter, F. Pohlandt, G. Gaedicke, W.M. Teller, Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol. (Copenh) 106(2), 227\u2013233 (1984)","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"2","key":"3807_CR62","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1210\/endo.142.2.7955","volume":"142","author":"P Divieti","year":"2001","unstructured":"P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Juppner, F.R. Bringhurst, Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142(2), 916\u2013925 (2001)","journal-title":"Endocrinology"},{"key":"3807_CR63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.physbeh.2017.09.005","volume":"181","author":"B Gellen","year":"2017","unstructured":"B. Gellen, D. Zelena, T.B. Usdin, A. Dobolyi, The parathyroid hormone 2 receptor participates in physiological and behavioral alterations of mother mice. Physiol. Behav. 181, 51\u201358 (2017)","journal-title":"Physiol. Behav."},{"issue":"3-4","key":"3807_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10606820213682","volume":"8","author":"TB Usdin","year":"2002","unstructured":"T.B. Usdin, T.I. Bonner, S.R. Hoare, The parathyroid hormone 2 (PTH2) receptor. Recept Channels 8(3-4), 211\u2013218 (2002)","journal-title":"Recept Channels"},{"issue":"3","key":"3807_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s42000-023-00459-1","volume":"22","author":"M Buttner","year":"2023","unstructured":"M. Buttner, D. Krogh, D. Fuhrer, C.T. Fuss, H.S. Willenberg, M. Luster, S. Singer, H. Siggelkow, Hypoparathyroidism\u2014management, information needs, and impact on daily living from the patients\u2019 perspective: results from a population-based survey. Hormones (Athens) 22(3), 467\u2013476 (2023)","journal-title":"Hormones (Athens)"},{"issue":"5","key":"3807_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4158\/EP13321.OR","volume":"20","author":"NL Cho","year":"2014","unstructured":"N.L. Cho, J. Moalem, L. Chen, C.C. Lubitz, F.D. Moore Jr, D.T. Ruan, Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr. Pract. 20(5), 427\u2013446 (2014)","journal-title":"Endocr. Pract."},{"issue":"5","key":"3807_CR67","doi-asserted-by":"publisher","first-page":"e0232842","DOI":"10.1371\/journal.pone.0232842","volume":"15","author":"SH Kim","year":"2020","unstructured":"S.H. Kim, Y. Rhee, Y.M. Kim, Y.J. Won, J. Noh, H. Moon, J. Lee, S.G. Kim, Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One 15(5), e0232842 (2020)","journal-title":"PLoS One"},{"issue":"12","key":"3807_CR68","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1055\/s-0042-118181","volume":"48","author":"G Leidig-Bruckner","year":"2016","unstructured":"G. Leidig-Bruckner, T. Bruckner, F. Raue, K. Frank-Raue, Long-term follow-up and treatment of postoperative permanent hypoparathyroidism in patients with medullary thyroid carcinoma: differences in complete and partial disease. Horm. Metab. Res. 48(12), 806\u2013813 (2016)","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"3807_CR69","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Postsurgical hypoparathyroidism-risk of fractures, psychiatric diseases, cancer, cataract, and infections. J. Bone Min. Res. 29(11), 2504\u20132510 (2014)","journal-title":"J. Bone Min. Res."},{"issue":"7","key":"3807_CR70","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00066-018-1288-0","volume":"194","author":"D Riedl","year":"2018","unstructured":"D. Riedl, R. Gastl, E. Gamper, C.R. Arnold, D. Dejaco, F. Schoellmann, G. Rumpold, Cancer patients\u2019 wish for psychological support during outpatient radiation therapy: Findings from a psychooncological monitoring program in clinical routine. Strahlenther. Onkol. 194(7), 655\u2013663 (2018)","journal-title":"Strahlenther. Onkol."},{"issue":"44","key":"3807_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7748\/ns.29.44.50.e9808","volume":"29","author":"CA Selmer","year":"2015","unstructured":"C.A. Selmer, Psychological needs of people living with cancer. Nurs. Stand. 29(44), 50\u201357 (2015)","journal-title":"Nurs. Stand."},{"issue":"12","key":"3807_CR72","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1055\/a-1400-2668","volume":"129","author":"I Anaforoglu","year":"2021","unstructured":"I. Anaforoglu, S. Sancak, E.M. Akbas, G.G. Oruk, M. Canat, K.A. Tezcan, Z.A. Uc, S. Gorar, G.C. Duman, G.F. Yaylali, M. Yilmaz, B.E. Bilir, H. Bozoglan, G. Akbaba, M.M. Tuna, S. Akcay, D. Tuzun, G.S. Bagir, F.E. Haydardedeoglu, G. Elbuken, G. Yorulmaz, O. Celik, M. Topbas, Effects of treatment adherence on quality of life in hypoparathyroid patients. Exp. Clin. Endocrinol. Diabetes 129(12), 918\u2013925 (2021)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"3807_CR73","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/joim.12865","volume":"285","author":"MC Astor","year":"2019","unstructured":"M.C. Astor, W. Zhu, S. Bjornsdottir, J. Bollerslev, O. Kampe, E.S. Husebye, Is there a need for an emergency card in hypoparathyroidism? J. Intern Med. 285(4), 429\u2013435 (2019)","journal-title":"J. Intern Med."},{"issue":"1","key":"3807_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/EJE-18-0580","volume":"180","author":"K David","year":"2019","unstructured":"K. David, C. Moyson, D. Vanderschueren, B. Decallonne, Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study. Eur. J. Endocrinol. 180(1), 71\u201378 (2019)","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"3807_CR75","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40618-020-01442-y","volume":"44","author":"NAT Hamdy","year":"2021","unstructured":"N.A.T. Hamdy, B. Decallonne, P. Evenepoel, D. Gruson, L. van Vlokhoven-Verhaegh, Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey. J. Endocrinol. Invest 44(7), 1437\u20131446 (2021)","journal-title":"J. Endocrinol. Invest"},{"issue":"2","key":"3807_CR76","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12020-021-02629-w","volume":"72","author":"AA Khan","year":"2021","unstructured":"A.A. Khan, H. AbuAlrob, Z. Punthakee, M. Shrayyef, R.E. Werfalli, H.A. Kassem, M. Braga, A. Millar, S. Hussain, S. Iqbal, T. Khan, T. Paul, S. Van Uum, J.E.M. Young, Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine 72(2), 553\u2013561 (2021)","journal-title":"Endocrine"},{"issue":"2","key":"3807_CR77","doi-asserted-by":"publisher","first-page":"bvaa181","DOI":"10.1210\/jendso\/bvaa181","volume":"5","author":"MB Zanchetta","year":"2021","unstructured":"M.B. Zanchetta, D. Robbiani, B. Oliveri, E. Giacoia, A. Frigeri, S. Kallsbrum, H. Salerni, S. Lucas, A. Diaz, B. Perez, L. Pieroni, M.A. Arce Lange, S. Tormo, A. Kitaigrodsky, A.M. Galich, Hipopara-red, real life experience in 322 patients with hypoparathyroidism. J. Endocr. Soc. 5(2), bvaa181 (2021)","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"3807_CR78","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/eje.1.02025","volume":"153","author":"EM Wekking","year":"2005","unstructured":"E.M. Wekking, B.C. Appelhof, E. Fliers, A.H. Schene, J. Huyser, J.G. Tijssen, W.M. Wiersinga, Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur. J. Endocrinol. 153(6), 747\u2013753 (2005)","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03807-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:32:23Z","timestamp":1720863143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03807-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03807-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Matthias B\u00fcttner has no relevant financial or non-financial interests to disclose. Susanne Singer has received funding from Lilly for reviewing papers for the Quality of Life Prize, outside of this work. Katherine Taylor has no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}